Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities


Osmetech is to acquire Molecular Sensing, the Melksham-based genetic analysis company, for £3.1m.

Osmetech, the developer of electronic odour sensors, has closed its Crewe headquarters with the loss of 20 jobs, in order to relocate its research and development operation to the US.

Osmetech has announced a £2.2m deal to acquire Roche's US-based OPTI range of blood gas analysers.

Osmetech is planning to raise a further £5.4m in a share issue, in order to fund the development of electronic odour sensors, provide working capital and finance acquisitions.

Osmetech has secured £5m of funding from GEM Global Yield Fund of the US to develop gas and odour sensors for medical use.